Dr. Sunita Parajuli, MD

Dr. Parajuli practices at Schulman and Schachne Institute for Nursing and Rehabilitation in Brooklyn, New York.

Dr. Parajuli's NPI, 1730444605, was assigned on July 6, 2012. Dr. Parajuli holds New York license 289192.

Dr. Parajuli's primary practice is Schulman and Schachne Institute for Nursing and Rehabilitation, at 555 Rockaway Parkway, Brooklyn, NY 11212 in Kings County. The practice phone is (718) 240-5775.

Dr. Parajuli's primary practice is Schulman and Schachne Institute for Nursing and Rehabilitation in Brooklyn, New York. Dr. Parajuli is also affiliated with White Plains Hospital. The medical group on file is Essen Medical Associates. Dmand AI also links Dr. Parajuli to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parajuli practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Parajuli's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Parajuli is licensed in New York.

CMS data shows 40 Medicare services from Dr. Parajuli across 1 procedure code in 2024, for 47 Medicare patients. Medicare paid $5,635 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Parajuli in 2024. The largest group is 85 and over, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parajuli's median patient age at 70, with 54% women.

In 2024, Dr. Parajuli wrote 438 Medicare Part D claims for 21 patients. 73% of them were for generic drugs. CMS names the drug for 330 of them, across 20 drugs with 11 or more claims each, at $169,322 in total drug cost. In 2023, CMS named 1,253 claims across 49 drugs.

Dr. Parajuli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 184 general payments to Dr. Parajuli from 26 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,506.